The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

By L. Bartalena, L. Baldeschi, K. Boboridis, A. Eckstein, G. Kahaly, C. Marcocci, P. Perros, M. Salvi, W. Wiersinga. European Thyroid Journal, 2016

867 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/696f45f81757df5046c966bbf7f5fa7003ae0d62

Citations in the corpus

• THE 2021 EUROPEAN GROUP ON GRAVES' ORBITOPATHY (EUGOGO) CLINICAL PRACTICE GUIDELINES FOR THE MEDICAL MANAGEMENT OF GRAVES' ORBITOPATHY. (2021, neutral): “Therefore, prior to starting treatment and after ruling out infections (white blood cell count), cardiovascular risk, liver enzymes, and markers of viral hepatitis are evaluated, in order to assess risks and contraindications (8).”